📗 Cite This Artifact
LRP10 Protein
LRP10 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LRP10 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">Signal peptide</td>
<td>1-19</td>
</tr>
<tr>
<td class="label">LDL receptor repeat</td>
<td>20-500</td>
</tr>
<tr>
<td class="label">EGF-like repeats</td>
<td>501-650</td>
</tr>
<tr>
<td class="label">** Transmembrane helix</td>
<td>2000-2022</td>
</tr>
<tr>
<td class="label">Cytoplasmic tail</td>
<td>2023-2245</td>
</tr>
<tr>
<td class="label">Aspect</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Inheritance</td>
<td>Risk factor (complex)</td>
</tr>
<tr>
<td class="label">Variants</td>
<td>Multiple rare coding variants</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Impaired protein clearance</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Protein clearance modulators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Endosomal trafficking drugs</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/a
LRP10 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LRP10 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">Signal peptide</td>
<td>1-19</td>
</tr>
<tr>
<td class="label">LDL receptor repeat</td>
<td>20-500</td>
</tr>
<tr>
<td class="label">EGF-like repeats</td>
<td>501-650</td>
</tr>
<tr>
<td class="label">** Transmembrane helix</td>
<td>2000-2022</td>
</tr>
<tr>
<td class="label">Cytoplasmic tail</td>
<td>2023-2245</td>
</tr>
<tr>
<td class="label">Aspect</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Inheritance</td>
<td>Risk factor (complex)</td>
</tr>
<tr>
<td class="label">Variants</td>
<td>Multiple rare coding variants</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Impaired protein clearance</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Protein clearance modulators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Endosomal trafficking drugs</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>
Lrp10 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
LRP10 (LDL Receptor-Related Protein 10) is a member of the low-density lipoprotein receptor family. LRP10 is a transmembrane receptor involved in endosomal-lysosomal trafficking and protein clearance. Rare coding variants in LRP10 are associated with an increased risk of Parkinson's disease and dementia with Lewy bodies.
Structure
Domain Architecture
Key Features
- Multiple ligand-binding repeats (LA modules)
- YXXΦ trafficking motifs in cytoplasmic tail
- NPXY and dileucine sorting signals
Normal Function
Endosomal Trafficking
LRP10 participates in receptor trafficking:
Protein Clearance
LRP10 is involved in:
- Misfolded protein clearance
- Autophagic flux
- Endosomal-lysosomal pathway function
Neuronal Function
- Expressed in dopaminergic [neurons](/entities/neurons)
- May participate in [alpha-synuclein](/mechanisms/alpha-synuclein) clearance
- Synaptic function maintenance
Role in Disease
Parkinson's Disease
Pathogenic Mechanisms:
- Endosomal-lysosomal dysfunction
- Impaired [alpha-synuclein](/proteins/alpha-synuclein) clearance
- Protein quality control defects
Dementia with Lewy Bodies
LRP10 variants associated with DLB:
- Similar mechanisms to PD
- May affect Lewy body formation
- Protein clearance pathway involvement
Therapeutic Strategies
Key Publications
See Also
- [LRP10 Gene](/proteins/LRP10-protein)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Dementia with Lewy Bodies](/diseases/lewy-body-dementia)
- [Alpha-Synuclein Pathway](/mechanisms/alpha-synuclein-aggregation-pathway)
- [GBA Gene](/proteins/gba-protein)
External Links
- [UniProt: Q9ULH7](https://www.uniprot.org/uniprot/Q9ULH7)
- [AlphaFold: Q9ULH7](https://alphafold.ebi.ac.uk/entry/Q9ULH7)
Background
The study of Lrp10 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-lrp10-protein |
| kg_node_id | LRP10PROTEIN |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-4bd27acfcf7e |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-lrp10-protein'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-lrp10-protein?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[LRP10 Protein](http://scidex.ai/artifact/wiki-proteins-lrp10-protein)
http://scidex.ai/artifact/wiki-proteins-lrp10-protein